![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 39, 36076-36084, September 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Medicine, Pharmacology, Chemistry, and
Pathology, Vanderbilt University School of Medicine,
Nashville, Tennessee 37232
Free radical-initiated oxidant injury
and lipid peroxidation have been implicated in a number of neural
disorders. Docosahexaenoic acid is the most abundant unsaturated fatty
acid in the central nervous system. We have shown previously that this
22-carbon fatty acid can yield, upon oxidation, isoprostane-like
compounds termed neuroprostanes, with E/D-type prostane rings
(E4/D4-neuroprostanes). Eicosanoids with
E/D-type prostane rings are unstable and dehydrate to
cyclopentenone-containing compounds possessing A-type and J-type prostane rings, respectively. We thus explored whether cyclopentenone neuroprostanes (A4/J4-neuroprostanes) are
formed from the dehydration of
E4/D4-neuroprostanes. Indeed, oxidation of
docosahexaenoic acid in vitro increased levels of putative
A4/J4-neuroprostanes 64-fold from 88 ± 43 to 5463 ± 2579 ng/mg docosahexaenoic acid. Chemical approaches
and liquid chromatography/electrospray ionization tandem mass
spectrometry definitively identified them as
A4/J4-neuroprostanes. We subsequently showed
these compounds are formed in significant amounts from a biological
source, rat brain synaptosomes.
A4/J4-neuroprostanes increased 13-fold, from a
basal level of 89 ± 72 ng/mg protein to 1187 ± 217 ng/mg
(n = 4), upon oxidation. We also detected these
compounds in very large amounts in fresh brain tissue from rats at
levels of 97 ± 25 ng/g brain tissue (n = 3) and
from humans at levels of 98 ± 26 ng/g brain tissue
(n = 5), quantities that are nearly an order of
magnitude higher than other classes of neuroprostanes. Because of the
fact that A4/J4-neuroprostanes contain highly
reactive cyclopentenone ring structures, it would be predicted that
they readily undergo Michael addition with glutathione and
adduct covalently to proteins. Indeed, incubation of
A4/J4-neuroprostanes in vitro with
excess glutathione resulted in the formation of large amounts of
adducts. Thus, these studies have identified novel, highly reactive
A/J-ring isoprostane-like compounds that are derived from
docosahexaenoic acid in vivo.
Recipient of a Burroughs Wellcome Fund Clinical Scientist Award in
Translational Research. To whom correspondence should be addressed: 526 RRB, Vanderbilt University School of Medicine, Nashville, TN
37232-6602. Tel.: 615-343-1124; Fax: 615-322-3669; E-mail:
jason.morrow@mcmail.vanderbilt.edu.
This article has been cited by other articles:
![]() |
J. D. Brooks, G. L. Milne, H. Yin, S. C. Sanchez, N. A. Porter, and J. D. Morrow Formation of Highly Reactive Cyclopentenone Isoprostane Compounds (A3/J3-Isoprostanes) in Vivo from Eicosapentaenoic Acid J. Biol. Chem., May 2, 2008; 283(18): 12043 - 12055. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Joy and E. A. Cowley 8-iso-PGE2 Stimulates Anion Efflux from Airway Epithelial Cells via the EP4 Prostanoid Receptor Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 143 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, J. Wang, K. R. Sekhar, H. Yin, N. F. Yared, S. N. Schneider, S. Sasi, T. P. Dalton, M. E. Anderson, J. Y. Chan, et al. Novel n-3 Fatty Acid Oxidation Products Activate Nrf2 by Destabilizing the Association between Keap1 and Cullin3 J. Biol. Chem., January 26, 2007; 282(4): 2529 - 2537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lawson, S. Kim, W. S. Powell, G. A. FitzGerald, and J. Rokach Oxidized derivatives of {omega}-3 fatty acids: identification of IPF3{alpha}-VI in human urine J. Lipid Res., November 1, 2006; 47(11): 2515 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Musiek, L. Gao, G. L. Milne, W. Han, M. B. Everhart, D. Wang, M. G. Backlund, R. N. DuBois, G. Zanoni, G. Vidari, et al. Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages J. Biol. Chem., October 21, 2005; 280(42): 35562 - 35570. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. MONTUSCHI, P. J. BARNES, and L. J. ROBERTS II Isoprostanes: markers and mediators of oxidative stress FASEB J, December 1, 2004; 18(15): 1791 - 1800. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |